-
Perrigo gains distribution rights to Zephrex-D and Tarex meth-blocking technology
DUBLIN - Perrigo on Tuesday announced an exclusive licensing agreement with Highland Pharmaceuticals for its Tarex methamphetamine blocking technology and the distribution rights of Zephrex-D (pseudoephedrine HCI 30 mg). Zephrex-D was developed using the Tarex technology and has been proven to be more than 98% effective at blocking one of the more common domestic methods of illegal meth production.